BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26046638)

  • 21. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leishmania donovani induces CD300a expression to dampen effector properties of CD11c
    Anand A; Singh R; Saini S; Mahapatra B; Singh A; Singh S; Singh RK
    Acta Trop; 2023 Mar; 239():106826. PubMed ID: 36610528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
    Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
    Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-Like Receptor 2 Targeted Rectification of Impaired CD8⁺ T Cell Functions in Experimental Leishmania donovani Infection Reinstates Host Protection.
    Bandyopadhyay S; Kar Mahapatra S; Paul Chowdhury B; Kumar Jha M; Das S; Halder K; Bhattacharyya Majumdar S; Saha B; Majumdar S
    PLoS One; 2015; 10(11):e0142800. PubMed ID: 26559815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain models.
    de Lemos ML; de la Torre AV; Petrov D; Brox S; Folch J; Pallàs M; Lazarowski A; Beas-Zarate C; Auladell C; Camins A
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1377-88. PubMed ID: 23603149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD40 signaling in CD8+CD40+ T cells turns on contra-T regulatory cell functions.
    Martin S; Pahari S; Sudan R; Saha B
    J Immunol; 2010 May; 184(10):5510-8. PubMed ID: 20400702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-2 induction of Blimp-1 is a key in vivo signal for CD8+ short-lived effector T cell differentiation.
    Boulet S; Daudelin JF; Labrecque N
    J Immunol; 2014 Aug; 193(4):1847-54. PubMed ID: 25015830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells.
    Silverman JM; Clos J; Horakova E; Wang AY; Wiesgigl M; Kelly I; Lynn MA; McMaster WR; Foster LJ; Levings MK; Reiner NE
    J Immunol; 2010 Nov; 185(9):5011-22. PubMed ID: 20881185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo.
    Xin L; Li Y; Soong L
    Infect Immun; 2007 Oct; 75(10):5018-26. PubMed ID: 17682041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia inducible factor 1α: A critical factor for the immune response to pathogens and Leishmania.
    Charpentier T; Hammami A; Stäger S
    Cell Immunol; 2016 Nov; 309():42-49. PubMed ID: 27372381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.
    Dubois A; Deruytter N; Adams B; Kanda A; Delbauve S; Fleury S; Torres D; François A; Pétein M; Goldman M; Dombrowicz D; Flamand V
    J Immunol; 2010 Jul; 185(2):884-91. PubMed ID: 20562264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IRF-5 Promotes Cell Death in CD4 T Cells during Chronic Infection.
    Fabié A; Mai LT; Dagenais-Lussier X; Hammami A; van Grevenynghe J; Stäger S
    Cell Rep; 2018 Jul; 24(5):1163-1175. PubMed ID: 30067973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marginal zone B cells regulate antigen-specific T cell responses during infection.
    Bankoti R; Gupta K; Levchenko A; Stäger S
    J Immunol; 2012 Apr; 188(8):3961-71. PubMed ID: 22412197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
    Agallou M; Margaroni M; Karagouni E
    Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
    Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
    J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar.
    Ghosh M; Mandal L; Maitra S; Rakshit S; Paul K; Bagchi J; Ganguly D; Pal C; Bandyopadhyay S
    J Infect Dis; 2006 Aug; 194(3):294-301. PubMed ID: 16826476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype.
    Resende M; Moreira D; Augusto J; Cunha J; Neves B; Cruz MT; Estaquier J; Cordeiro-da-Silva A; Silvestre R
    J Immunol; 2013 Jul; 191(1):262-73. PubMed ID: 23729437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.